tcr1020-cd8 t cells
Cell therapyexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2025 (NCT06707896)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- GTPase KRasImmunity, passive
KRAS immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06707896 | Phase 1 | Feb 1, 2025 | Lustgarten Foundation, Stand Up To Cancer, University of Pennsylvania |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lustgarten Foundation | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Stand Up To Cancer | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Pennsylvania | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1